On December 7, 2013, America’s No. 1 tennis player, John Isner, held his annual charity event, the Ebix Charity Challenge, contributing $75,000 to UNC Lineberger
Screening to detect medical conditions has become standard practice for many diseases, but insufficient attention has been paid to the potential for harm, according to research by a team led by Russell Harris, MD, MPH, of the UNC School of Medicine, UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center member.
We are deeply grateful to the thousands of donors who help make UNC Lineberger’s cancer fight possible by supporting innovative and lifesaving cancer research and care. Here are important year-end gift deadlines and reminders to receive tax benefits for calendar 2014.
James Evans, MD, PhD, published his thoughts on the 23andMe genetic testing controversy in the Dec. 13 issue of The Cancer Letter.
The award recognizes Hyman B. Muss, MD, for his years of service to the Richard L. Schilsky Cancer and Leukemia Group B cooperative group.
A new study shows combined therapy is linked to a lower chance of recurrence in women with small, HER2+ breast cancers.
UNC Lineberger's Single Fathers Due to Cancer program featured in the Chapel Hill News.
The National Academy of Inventors Fellows were nominated by their peers for outstanding contributions to innovation.
UNC Lineberger members Charles Perou, PhD, Lisa Carey, MD, Carey Anders, MD, and Hyman B. Muss, MD will present at symposium.
N.C. Cancer Hospital patient, Jim MacDonald, worked with songwriter, Emily Lynch, to write a song about his cancer experience, "Every Day is Christmas.”
Five questions for Yisong Wan, PhD, a new Jefferson-Pilot fellow who is uncovering the roles of T cells in disease cures and causes.
Director of the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center and colleagues at the FDA guide drug developers on how to include meaningful pain endpoints when designing cancer trials.
The Carolina Pediatric Attention, Love, and Support program pairs UNC students with young people undergoing treatment for cancer and blood disorders, Josephine Yurcaba of the Daily Tar Heel reports.
Bruce Ham, one of the original members of the Single Fathers Due to Cancer support group, has written a memoir, “Laughter, Tears and Braids,” about his journey raising three daughters after the death of his wife from cancer.
The largest-ever population-based study of breast cancer in North Carolina is poised to begin the five year follow-up phase.
The Tuesday after Thanksgiving is intended to create a national movement around the holidays dedicated to giving.
A new study led by Christine Rini, PhD, finds that survivors of hematopoietic stem cell transplant, an aggressive treatment for blood cancers, benefited from a two-part peer support process the authors call expressive helping.
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, was quoted on National Public Radio's All Things Considered regarding the Food and Drug Administration's warning letter sent to the company 23andMe demanding that its saliva test be taken off the market.
Give back this holiday season by registering with Be The Match on UNC’s campus on December 2 and 3, 2013.
Stella Waugh, a cancer survivor, is thankful to have family together for Thanksgiving, April Dudash of the Durham Herald-Sun reports.
For the fifth straight year, UNC Libraries and campus collect books for the Pediatric Hematology-Oncology clinic.
A study of 2,519 Kenyan men conducted by researchers at the University of North Carolina revealed that infection with the human papillomavirus (HPV) was associated with a higher subsequent risk of infection with HIV, a precursor to AIDS.
A Dare County, N.C., wife and mother of three keeps her spunky, positive spirit intact during treatment for thyroid cancer, buoying herself, her family and her medical team on the journey.
William Zamboni, PharmD, PhD, has developed a probe to measure the body’s immune function to help physicians deliver accurate, individualized doses for cancer patients prescribed nanoparticle-based drugs
The inaugural geriatric oncology symposium, geared toward a lay audience, provided a lively afternoon of presentations, questions and answers, and concluded with a reception on Friday, November 15, 2013.